• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用大数据于儿科开发项目:2016 年美国临床药理学会年会座谈会的会议录。

Leveraging Big Data in Pediatric Development Programs: Proceedings From the 2016 American College of Clinical Pharmacology Annual Meeting Symposium.

机构信息

U.S. Food and Drug Administration, Silver Spring, Maryland, USA.

Projections Research Inc, Phoenixville, Pennsylvania, USA.

出版信息

Clin Pharmacol Ther. 2018 Jul;104(1):81-87. doi: 10.1002/cpt.975. Epub 2018 Jan 10.

DOI:10.1002/cpt.975
PMID:29319159
Abstract

This article discusses the use of big data in pediatric drug development. The article covers key topics discussed at the ACCP annual meeting symposium in 2016 including the extent to which big data or real-world data can inform clinical trial design and substitute for efficacy and safety data typically obtained in clinical trials. The current states of use, opportunities, and challenges with the use of big data in future pediatric drug development are discussed.

摘要

本文讨论了大数据在儿科药物开发中的应用。本文涵盖了 2016 年 ACCP 年会研讨会讨论的关键主题,包括大数据或真实世界数据在多大程度上可以为临床试验设计提供信息,并替代通常在临床试验中获得的疗效和安全性数据。讨论了大数据在未来儿科药物开发中的使用现状、机遇和挑战。

相似文献

1
Leveraging Big Data in Pediatric Development Programs: Proceedings From the 2016 American College of Clinical Pharmacology Annual Meeting Symposium.利用大数据于儿科开发项目:2016 年美国临床药理学会年会座谈会的会议录。
Clin Pharmacol Ther. 2018 Jul;104(1):81-87. doi: 10.1002/cpt.975. Epub 2018 Jan 10.
2
Achieving big with small: quantitative clinical pharmacology tools for drug development in pediatric rare diseases.以小博大:儿科罕见病药物研发的定量临床药理学工具。
J Pharmacokinet Pharmacodyn. 2023 Dec;50(6):429-444. doi: 10.1007/s10928-023-09863-x. Epub 2023 May 4.
3
Breaking Down Barriers to Effective Patient Care.打破有效患者护理的障碍。
Clin Pharmacol Ther. 2018 Mar;103(3):360-364. doi: 10.1002/cpt.1026.
4
Clinical Pharmacology Regulatory Sciences in Drug Development and Precision Medicine: Current Status and Emerging Trends.药物研发与精准医学中的临床药理学监管科学:现状与新兴趋势。
AAPS J. 2021 Apr 12;23(3):54. doi: 10.1208/s12248-021-00563-3.
5
Advancing pediatric drug development in South Asia: Current landscape and vision for the future.推进南亚儿科药物研发:现状与未来展望。
Indian J Pharmacol. 2024 Jul 1;56(4):285-289. doi: 10.4103/ijp.ijp_396_24. Epub 2024 Sep 10.
6
Big Data in the Assessment of Pediatric Medication Safety.大数据在儿科药物安全评估中的应用。
Pediatrics. 2020 Feb;145(2). doi: 10.1542/peds.2019-0562. Epub 2020 Jan 14.
7
Identifying the "Blip on the Radar Screen": Leveraging Big Data in Defining Drug Safety and Efficacy in Pediatric Practice.发现“雷达屏幕上的亮点”:利用大数据在儿科实践中定义药物安全性和疗效。
J Clin Pharmacol. 2018 Oct;58 Suppl 10:S86-S93. doi: 10.1002/jcph.1141.
8
Where Will Statistical Sciences for Clinical Pharmacology Be in 2030?到2030年临床药理学的统计学将何去何从?
Clin Pharmacol Ther. 2020 Jan;107(1):17-21. doi: 10.1002/cpt.1635.
9
Statement of the American College of Clinical Pharmacology on Drug Regulation Reform Act.
J Clin Pharmacol. 1979 Feb-Mar;19(2-3):165-6. doi: 10.1002/j.1552-4604.1979.tb02475.x.
10
Pediatric Drug Development: Outlook for Science-Based Innovation.儿科药物研发:基于科学创新的展望。
Clin Pharmacol Ther. 2018 Mar;103(3):376-378. doi: 10.1002/cpt.1001. Epub 2018 Jan 31.

引用本文的文献

1
The Blind Spot of Pharmacology: A Scoping Review of Drug Metabolism in Prematurely Born Children.药理学的盲点:对早产儿药物代谢的范围综述
Front Pharmacol. 2022 Feb 15;13:828010. doi: 10.3389/fphar.2022.828010. eCollection 2022.
2
Pediatric data from the research program: demonstration of pediatric obesity over time.来自该研究项目的儿科数据:随时间推移的儿童肥胖症实证
JAMIA Open. 2021 Dec 28;4(4):ooab112. doi: 10.1093/jamiaopen/ooab112. eCollection 2021 Oct.
3
Adequacy of safety data for regulatory approval of pediatric indication through extrapolation algorithm.
通过外推算法获得用于儿科适应症监管批准的安全性数据的充分性。
Transl Clin Pharmacol. 2021 Jun;29(2):73-77. doi: 10.12793/tcp.2021.29.e11. Epub 2021 Jun 21.
4
The best pharmaceuticals for children-what can we do?儿童最佳药物——我们能做些什么?
Transl Pediatr. 2020 Apr;9(2):86-92. doi: 10.21037/tp.2020.02.07.
5
Regulatory innovation for expansion of indications and pediatric drug development.扩大适应症及儿科药物研发的监管创新
Transl Clin Pharmacol. 2018 Dec;26(4):155-159. doi: 10.12793/tcp.2018.26.4.155. Epub 2018 Dec 19.
6
Oral Drug Delivery Technologies-A Decade of Developments.口服药物递送技术:十年发展历程。
J Pharmacol Exp Ther. 2019 Sep;370(3):529-543. doi: 10.1124/jpet.118.255828. Epub 2019 Apr 22.